格隆汇3月9日丨科济药业-B(02171.HK)宣布,于2026年3月9日,公司根据首次公开发售后购股权计划的条款向181名购股权承授人授出426.7万份购股权,惟须待购股权承授人接纳后方可作实。
格隆汇3月9日丨科济药业-B(02171.HK)宣布,于2026年3月9日,公司根据首次公开发售后购股权计划的条款向181名购股权承授人授出426.7万份购股权,惟须待购股权承授人接纳后方可作实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.